Prucalopride Succinate
Brand name: Motegrity
Rank #468 of 500 drugs by total cost
$15.7M
Total Cost
22,068
Total Claims
$15.7M
Total Cost
994
Prescribers
$712
Cost per Claim
1,351
Beneficiaries
29,541
30-Day Fills
$16K
Avg Cost/Provider
22
Avg Claims/Provider
About Prucalopride Succinate
Prucalopride Succinate (sold as Motegrity) was prescribed 22,068 times by 994 Medicare Part D providers in 2023, costing the program $15.7M. At $712 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 465 | Digoxin (Digoxin) | $15.9M | 548,410 |
| 466 | Alpelisib (Piqray) | $15.7M | 747 |
| 467 | Doxazosin Mesylate (Doxazosin Mesylate) | $15.7M | 729,878 |
| 468 | Prucalopride Succinate (Motegrity) | $15.7M | 22,068 |
| 469 | Ketorolac Tromethamine (Ketorolac Tromethamine) | $15.6M | 582,750 |
| 470 | Tetrabenazine (Tetrabenazine) | $15.6M | 6,326 |
| 471 | Avatrombopag Maleate (Doptelet) | $15.4M | 1,156 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology